Additional blood sampling
Additional blood sampling is a biological therapy with 8 clinical trials. Currently 5 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
5
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry
The Skin Microbiome in Graft Versus Host Disease
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)
Clinical Trials (8)
Prognostic Value of NETosis Markers for Thrombosis During Myeloproliferative Neoplasms (AVATARE)
A Pilot Study for Systematic Neonatal Screening for Lysosomal Storage Diseases Using Tandem Mass Spectrometry
The Skin Microbiome in Graft Versus Host Disease
Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)
Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)
Metabolomics Predict Therapy Response
Study on the Response to Tetanus Vaccination of People Living With HIV
Model for PK/PD of Antimicrobials in Blood Stream Infection: Feasibility
All 8 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 8